Materialise NV (MTLS) Stock Price, Quote & News

AI Score

Unlock

AI Score

Our AI model analyzes fundamental, technical, and statistical indicators to predict the probability of a bullish trend over the next three months.

We regularly update and refine our models to deliver the most reliable forecasts for you.

Bullish Probability	Sentiment	Score
+80%	Strong Buy	10
+75%	Buy	9
+70%	Buy	8
+60%	Buy	7
+50%	Hold	6
+45%	Hold	5
+40%	Hold	4
+35%	Sell	3
+30%	Sell	2
+20%	Strong Sell	1

Materialise NV (MTLS)

AI Score

Unlock

AI Score

Bullish Probability	Sentiment	Score
+80%	Strong Buy	10
+75%	Buy	9
+70%	Buy	8
+60%	Buy	7
+50%	Hold	6
+45%	Hold	5
+40%	Hold	4
+35%	Sell	3
+30%	Sell	2
+20%	Strong Sell	1

7.53

0.38 (5.31%)

At close: Jan 14, 2025, 3:59 PM

7.53

0.07%

After-hours Jan 14, 2025, 04:00 PM EST

undefined% (undefined)

Bid	7.4
Market Cap	444.48M
Revenue (ttm)	-
Net Income (ttm)	-
EPS (ttm)	0.18
PE Ratio (ttm)	41.81
Forward PE	n/a
Analyst	Buy

Ask	8.33
Volume	117,212
Avg. Volume (20D)	203,236
Open	7.14
Previous Close	7.15
Day's Range	7.12 - 7.64
52-Week Range	4.70 - 8.50
Beta	undefined

About MTLS

Materialise NV provides additive manufacturing and medical software, and 3D printing services in the Americas, Europe and Africa, and the Asia-Pacific. The company operates through three segments: Materialise Software, Materialise Medical, and Materialise Manufacturing. Its Materialise Software segment offers software through programs and platforms that enable and enhance the functionality of 3D printers and of 3D printing operations. Its softwar...

[Show more]

Industry Software - Application

Sector Technology

IPO Date Jun 25, 2014

Employees 2,437

Stock Exchange NASDAQ

Ticker Symbol MTLS

Website https://www.materialise.com

Analyst Forecast

According to 1 analyst ratings, the average rating for MTLS stock is "Buy." The 12-month stock price forecast is $9.5, which is an increase of 26.25% from the latest price.

Buy 100.00%

Hold 0.00%

Sell 0.00%

Stock Forecasts

Next Earnings Release

Materialise NV is scheduled to release its earnings on Feb 19, 2025, before market opens.
Analysts project revenue of $70.70M, reflecting a -2.01% YoY shrinking and earnings per share of 0.05, making a 0.00% YoY.

Why Price Moved

2 months ago · Source

+18.27%

Materialise shares are trading higher after the co... Unlock content with Pro Subscription

5 months ago · Source

-9.58%

Shares of stocks in the broader tech sector are trading lower amid a sell off due to US economy concerns.

News

1 month ago · zacks.com

Materialise (MTLS) Is a Great Choice for 'Trend' Investors, Here's Why

Materialise (MTLS) could be a solid choice for shorter-term investors looking to capitalize on the recent price trend in fundamentally sound stocks. It is one of the many stocks that passed through ou...

1 month ago · zacks.com

Should Value Investors Buy Materialise (MTLS) Stock?

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest...

1 month ago · zacks.com

Here's Why Momentum in Materialise (MTLS) Should Keep going

Materialise (MTLS) made it through our "Recent Price Strength" screen and could be a great choice for investors looking to make a profit from stocks that are currently on the move.

2 months ago · seekingalpha.com

Materialise: Strong Q3 Results Despite Ongoing Market Headwinds

Materialise continues to grow on the back of its Medical segment, which is expanding at a rapid pace. Materialise's margins will continue to improve going forward, driven by a combination of revenue m...

2 months ago · zacks.com

Are Investors Undervaluing Materialise (MTLS) Right Now?

2 months ago · zacks.com

What Makes Materialise (MTLS) a New Buy Stock

Materialise (MTLS) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.

2 months ago · seekingalpha.com

Materialise: Medical Business Unit Is The Hidden Value

Materialise NV is a Belgian additive manufacturing company, showing a 14.18% CAGR in its Medical segment from FY18 to FY23. Despite mixed results in other segments, Materialise maintains profitability...

2 months ago · seekingalpha.com

Materialise NV (MTLS) Q3 2024 Earnings Call Transcript

Materialise NV (NASDAQ:MTLS ) Q3 2024 Earnings Conference Call October 24, 2024 8:30 AM ET Company Participants Harriet Fried - Investor Relations-Lippert/Heilshorn & Associates Brigitte de Vet-Veithe...

2 months ago · businesswire.com

Materialise Reports Third Quarter 2024 Results

LEUVEN, Belgium--(BUSINESS WIRE)--Materialise NV (NASDAQ:MTLS), a leading provider of additive manufacturing and medical software and of sophisticated 3D printing services, today announced its financi...